Underwriter’s Warrant. The Company hereby agrees to issue and sell to the Underwriter (and/or its permitted designees) on each Closing Date a warrant to purchase an amount of Shares (“Underwriter’s Warrant”), equal to an aggregate of ten percent (10%) of the Shares underlying the Units (the “Underwriter’s Warrant Shares”) sold in the Offering, for an aggregate purchase price of $10.00 at the Initial Closing Date. The Underwriter’s Warrant, in substantially the form attached hereto as Exhibit A, shall be exercisable, in whole or in part, commencing on a date which is 180 days after the Qualification Date (as defined below) or commencement of sales of the Units in the Offering and expiring on the fifth-year anniversary of the Qualification Date (as defined below) at an initial exercise price per share of $7.50, which is equal to 125% of the Offering Price of the Units; provided that such exercise period shall not exceed five (5) years from the Qualification Date of the Offering Statement pursuant to FINRA Rule 5110(f)(2)(G)(i). The Underwriter’s Warrants and the Underwriter’s Warrant Shares are hereinafter referred to together as the “Underwriter’s Securities”. The Underwriter understands and agrees that there are significant restrictions pursuant to the Financial Industry Regulatory Authority’s (“FINRA”) Rule 5110 against transferring the Underwriter’s Securities during the one hundred eighty (180) days after the Qualification Date or commencement date of sales of Units in the Offering and by its acceptance thereof, the Underwriter agrees that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Securities, or any portion thereof, and that it will not engage in any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the Underwriter’s Securities for a period of one hundred eighty (180) days following the Qualification Date of commencement date of sales of Units in the Offering to anyone other than (i) a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Underwriter or selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions. Delivery of an Underwriter’s Warrant shall be made on each Closing Date and shall be issued in the name or names and in such authorized denominations as the Underwriter may request.
Underwriter’s Warrant. The Underwriter’s Warrant, substantially in the form of Exhibit E hereto, executed by the officers of the Company, delivered to the Underwriter on or before the date hereof, shall be in full force and effect on the Closing Date or any Additional Closing Date, as the case may be.
Underwriter’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date and Option Closing Date (if applicable), Warrants, substantially in the form of Exhibit A attached hereto, to purchase such number of shares of Common Stock equal to six percent (6.0%) of the Offered Securities sold by the Company (the “Underwriter’s Warrant”), including any shares of Common Stock issued pursuant to the exercise of Over-allotment Option. The Underwriter’s Warrant shall be exercisable, in whole or in part, commencing six months from issuance and expiring on the fifth-year anniversary of the commencement of sale of the Offering at an initial exercise price of $[●] per shares of Common Stock, which is equal to one hundred and ten percent (110%) of the initial public offering price of a Firm Share.
Underwriter’s Warrant. On the First Closing Date, the Company will issue to you, for a consideration of $5.00 and upon the terms and conditions set forth in the form of Underwriter's Warrant annexed as an exhibit to the Registration Statement, an Underwriter's Warrant to purchase 250,000 Shares. In the event of conflict in the terms of this Agreement and the Underwriter's Warrant, the language of the Underwriter's Warrant shall control.
Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriters on the applicable Closing Date as compensation, Warrants, substantially in the form of Exhibit B attached hereto, to purchase such number of Ordinary Shares equal to six percent (6%) of the Offering (the “Underwriters’ Warrant”). The Underwriters’ Warrant shall be exercisable, in whole or in part, commencing anytime from the date of issuance and expiring on the fifth-year anniversary of the commencement of sales in the Offering at an initial exercise price of $[●]1per share, which is equal to one hundred and twenty-five percent (125%) of the initial public offering price of a Firm Share. 1 125% of the Offering Price
Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on the applicable Closing Date, Warrants to purchase such number of Shares equal to six percent (6%) of the Firm Shares issued at the Closing (for the avoidance of doubt, not including the Additional Shares) (the “Underwriter’s Warrant”). The Underwriter’s Warrant shall be exercisable, in whole or in part, commencing anytime from the date of issuance and expiring on the fifth-year anniversary of the effective date of the Offering at an initial exercise price of $[●] per Ordinary Share, which is equal to one hundred ten percent (110%) of the initial public offering price of a Firm Share. The Underwriter’s Warrant and the Ordinary Shares issuable upon exercise of the Underwriter’s Warrant are hereinafter referred to collectively as the “Underwriter’s Securities.” The Firm Shares, the Additional Shares and the Underwriter’s Securities are hereinafter referred to collectively as the “Securities.”
Underwriter’s Warrant. On or prior to the Closing Date, the Company shall deliver to the Representatives warrants (the "Underwriter's Warrants"), at an aggregate purchase price of $100, to purchase Shares equal to 10% of the Firm Shares sold in the Offering, which Underwriter's Warrants shall be exercisable for a per Share exercise price equal to 120% of the per Share public offering price of the Firm Shares.
Underwriter’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date, Warrants, substantially in the form of Exhibit A attached hereto, to purchase such number of Shares equal to eight percent (8%) of the Offered Securities sold by the Company (the “Underwriter’s Warrant”). The Underwriter’s Warrant shall be exercisable, in whole or in part, commencing anytime from the date of issuance and expiring on the fifth-year anniversary of the commencement of sale of the Offering at an initial exercise price of $[●] per Ordinary Share, which is equal to one hundred fifteen percent (115%) of the initial public offering price of a Firm Share.
Underwriter’s Warrant. On or before each Closing Date, the Underwriter shall have received executed copies of the Underwriter’s Warrant.
Underwriter’s Warrant. On or prior to the Closing Date, the Company shall deliver to the Representative warrants (the "Underwriter's Warrants"), at an aggregate purchase price of $100, to purchase Shares equal to 10% of the Firm Shares sold in the Offering, which Underwriter's Warrants shall be exercisable for a per Share exercise price equal to 155% of the per Share public offering price of the Firm Shares.
